Handelsinvest Investeringsforvaltning »

Blueprint Medicines shares owned by Handelsinvest Investeringsforvaltning

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Handelsinvest Investeringsforvaltning from 13F filings

Historical chart of Handelsinvest Investeringsforvaltning investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Handelsinvest Investeringsforvaltning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Handelsinvest Investeringsforvaltning

Quarter filed Position value Share count Share price at filing
2024-03-31 $368k 3.9k 94.94
2023-12-31 $543k 5.9k 92.22

More positions owned by Handelsinvest Investeringsforvaltning

Microsoft Corp Common Stock (MSFT)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
JPMorgan Chase & Co Common Stock (JPM)
Eli Lilly & Co Common Stock (LLY)
Broadcom Common Stock (AVGO)
Visa Common Stock (V)
Mastercard Common Stock (MA)
UnitedHealth Group Common Stock (UNH)
Procter & Gamble Co/The Common Stock (PG)
Merck & Co Common Stock (MRK)
Alphabet Common Stock (GOOG)

View all positions for Handelsinvest Investeringsforvaltning

Top funds holding Blueprint Medicines

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Rock Springs Capital Management
State Street Corporation
Jane Street
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Alliancebernstein
Invesco

View all funds holding Blueprint Medicines